RARA and acute promyelocytic leukemia: In clinic, one BCOR-RARA-positive APL patient achieved CR via accepting ATRA plus IA regimen, but ATO or tamibarotene did not function in the induction at the first relapse; the other patient directly accepted IA regimen and reached to CR.